Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.67B |
| 2 |
Apple
AAPL
|
+$1.5B |
| 3 |
Tesla
TSLA
|
+$1.38B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.27B |
| 5 |
Mastercard
MA
|
+$1.1B |
Top Sells
| 1 |
Honeywell
HON
|
+$1.28B |
| 2 |
Phillips 66
PSX
|
+$651M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$503M |
| 4 |
Materials Select Sector SPDR Fund
XLB
|
+$425M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$377M |
Sector Composition
| 1 | Technology | 28.23% |
| 2 | Financials | 14.76% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Healthcare | 8.95% |
| 5 | Communication Services | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Forge Global Holdings
FRGE
$242M
| $67K | ﹤0.01% |
7,891
-3,794
| -32% | -$32.2K |
|
3677
FT Vest US Equity Buffer ETF September
FSEP
$953M
| $67K | ﹤0.01% |
1,502
-1,736
| -54% | -$77.4K |
|
3678
First Savings Financial Group
FSFG
$193M
| $67K | ﹤0.01% |
2,590
-207
| -7% | -$5.36K |
|
3679
Lexicon Pharmaceuticals
LXRX
$403M
| $67K | ﹤0.01% |
146,071
-97,245
| -40% | -$44.6K |
|
3680
Acrivon Therapeutics
ACRV
$48.8M
| $66K | ﹤0.01% |
32,698
-5,393
| -14% | -$10.9K |
|
3681
Corbus Pharmaceuticals
CRBP
$116M
| $66K | ﹤0.01% |
12,470
-5,686
| -31% | -$30.1K |
|
3682
FT Vest US Equity Deep Buffer ETF October
DOCT
$301M
| $66K | ﹤0.01% |
1,721
-2,018
| -54% | -$77.4K |
|
3683
FT Vest US Equity Buffer ETF August
FAUG
$985M
| $66K | ﹤0.01% |
1,441
-1,238
| -46% | -$56.7K |
|
3684
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.32B
| $66K | ﹤0.01% |
2,733
| – | – |
|
3685
Cassava Sciences
SAVA
$104M
| $66K | ﹤0.01% |
44,130
-49,449
| -53% | -$74K |
|
3686
Telomir Pharmaceuticals
TELO
$46.3M
| $66K | ﹤0.01% |
20,339
-9,620
| -32% | -$31.2K |
|
3687
Gyre Therapeutics
GYRE
$738M
| $65K | ﹤0.01% |
8,451
-2,092
| -20% | -$16.1K |
|
3688
FiscalNote
NOTE
$73.3M
| $65K | ﹤0.01% |
6,693
-1,585
| -19% | -$15.4K |
|
3689
OP Bancorp
OPBK
$218M
| $65K | ﹤0.01% |
5,456
-4,590
| -46% | -$54.7K |
|
3690
FreightCar America
RAIL
$162M
| $65K | ﹤0.01% |
11,743
-9,702
| -45% | -$53.7K |
|
3691
Lunai Bioworks Inc. Common Stock
RENB
$46.3M
| $65K | ﹤0.01% |
119,828
-60,016
| -33% | -$32.6K |
|
3692
Suburban Propane Partners
SPH
$1.22B
| $65K | ﹤0.01% |
3,085
+116
| +4% | +$2.44K |
|
3693
Stem
STEM
$122M
| $65K | ﹤0.01% |
9,231
-2,406
| -21% | -$16.9K |
|
3694
XBiotech
XBIT
$86M
| $65K | ﹤0.01% |
20,108
-9,896
| -33% | -$32K |
|
3695
Zegna
ZGN
$2.25B
| $65K | ﹤0.01% |
8,744
| – | – |
|
3696
Actinium Pharmaceuticals
ATNM
$52.4M
| $64K | ﹤0.01% |
39,871
-9,989
| -20% | -$16K |
|
3697
Canadian Solar
CSIQ
$722M
| $64K | ﹤0.01% |
7,439
-3,417
| -31% | -$29.4K |
|
3698
Cemex
CX
$13.8B
| $64K | ﹤0.01% |
11,384
+1,625
| +17% | +$9.14K |
|
3699
Greenwich LifeSciences
GLSI
$156M
| $64K | ﹤0.01% |
6,633
-3,015
| -31% | -$29.1K |
|
|
SOHU
3700
Sohu.com
SOHU
$481M
| $64K | ﹤0.01% |
4,842
+3,696
| +323% | +$48.9K |
|